Search results for "Phase 3 clinical trial"

Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.6% in Phase 3 clinical trials, though it did...
GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition

GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition

A new oral therapy is now available for patients with ROS1-positive lung cancer whose disease has progressed following initial treatment or spread to...
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data

HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data

HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...
Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market

Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market

The glucagon-like peptide-1 (GLP-1) obesity treatment market, long dominated by subcutaneous injections, is rapidly...
Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68

Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68

Celltrion announced on July 15 that it has received approval from South Korea’s Ministry of Food and Drug Safety for an...
Daewoong’s Enblo Demonstrates Strong Potential to Reverse Fatty Liver in Diabetes Patients

Daewoong’s Enblo Demonstrates Strong Potential to Reverse Fatty Liver in Diabetes Patients

Daewoong Pharmaceutical announced that its newly developed type 2 diabetes medication, Enblo (active ingredient:...
AI Trained on 200,000 Patient Records Predicts Early Mortality Risk in Severe Trauma

AI Trained on 200,000 Patient Records Predicts Early Mortality Risk in Severe Trauma

“Can we save this patient? Should we send them straight to the operating room, or does the intensive care unit come...
New Non-Invasive MRI Method Visualizes Elusive Liver and Intestinal Lymph Vessels

New Non-Invasive MRI Method Visualizes Elusive Liver and Intestinal Lymph Vessels

South Korean researchers have developed a breakthrough MRI technique that images the body’s lymphatic system without an...
United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy

United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy

The race to develop regenerative cell therapies for an ultra-rare disease that leaves patients born without a...
ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients

ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients

South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor...